English  |  正體中文  |  简体中文  |  Items with full text/Total items : 12145/12927 (94%)
Visitors : 935749      Online Users : 392
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
    •  Adv. Search
    Home ‧ Login ‧ Upload ‧ Help ‧ About ‧ Administer Goto mobile version

    Category

    Loading community tree, please wait....

    Year

    Loading year class tree, please wait....

    Items for Author "Tsai, KY" 

    Return to Browse by Author

    Showing 8 items.

    Collection Date Title Relation Bitstream
    [劉滄梧] 期刊論文 2022-02 Clinical outcomes of Taiwanese patients with resected oral cavity squamous cell carcinoma who underwent Reconstruction with free versus local flaps -
    [劉滄梧] 期刊論文 2021-05-26 Adequate surgical margins for oral cancer: A Taiwan cancer registry national database analysis -
    [鄒小蕙] 期刊論文 2019-06 Sequential therapy of neoadjuvant biochemotherapy with cetuximab, paclitaxel, and cisplatin followed by cetuximab-based concurrent bioradiotherapy in high-risk locally advanced oral squamous cell carcinoma: Final analysis of a phase 2 clinical trial -
    [劉滄梧] 期刊論文 2018-07 Adjuvant radiotherapy after curative surgery for oral cavity squamous cell carcinoma and treatment effect of timing and duration on outcome-A Taiwan Cancer Registry national database analysis -
    [劉滄梧] 期刊論文 2017-04 Comparative clinical outcomes of Taiwanese patients with resected buccal and tongue squamous cell carcinomas -
    [劉滄梧] 期刊論文 2017-03 Clinical outcomes of Taiwanese patients with cT4 oral cavity squamous cell carcinoma: Toward the identification of the optimal initial treatment approach for cT4b patients -
    [劉滄梧] 期刊論文 2017-02 Association between the diagnosis-to-treatment interval and overall survival in Taiwanese patients with oral cavity squamous cell carcinoma -
    [張光裕] 會議論文/會議摘要 2011-09-23 A phase II study of neoadjuvant bio-chemotherapy with Cetuximab, Paclitaxel, and Cisplatin (CPC) followed by Cetuximab-based concurrent bio-radiotherapy in high-risk locally advanced head and neck cancer - representative of head and neck cancer study grou -

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback